Cambridge Investment Research Advisors
DCOY

Cambridge Investment Research Advisors’s Decoy Therapeutics DCOY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$4K – 3203
2022
Q3 		$4K Hold
1
– – ﹤0.01% 3038
2022
Q2 		$4K Hold
1
– – ﹤0.01% 3034
2022
Q1 		$8K Buy
+1
New +$15.8K ﹤0.01% 3147
2019
Q1 		– Hold
0
– -$3K – 2348
2018
Q4 		– Hold
0
– – – 2144

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cambridge Investment Research Advisors's DCOY Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Decoy Therapeutics (DCOY) in Q4 2022, closing a stake of 1 share — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in DCOY in Q1 2022 and held it in 3 quarters. The position peaked at $8K in Q1 2022. 4 funds tracked by Wall St. Rank hold DCOY as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining Decoy Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1 Decoy Therapeutics share in Q4 2022, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in Decoy Therapeutics in Q1 2022 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Decoy Therapeutics position peaked at $8K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.